ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

House Subcommittee To Hold Hearings On Cancer Program

June 10, 1977

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002